NCT02516540

Brief Summary

The hypothesis of this 3 year, prospective randomized multicenter efficacy trial is that a structured life-style intervention program with exercise training and mediterranean diet is effective regarding increased adherence to a mediterranean diet, reduction of body mass index, and increase of physical fitness.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
600

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Mar 2015

Longer than P75 for not_applicable

Geographic Reach
1 country

19 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2015

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 22, 2015

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 6, 2015

Completed
9.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2025

Completed
Last Updated

April 11, 2024

Status Verified

April 1, 2024

Enrollment Period

10 years

First QC Date

July 22, 2015

Last Update Submit

April 10, 2024

Conditions

Keywords

hereditary breast and ovarian cancer (HBOC)BRCA1/2 mutation carriersMediterranean dietStructured exercise trainingprevention

Outcome Measures

Primary Outcomes (3)

  • Mediterranean Diet Adherence Screener (MEDAS) Score (Questionnaire)

    Adherence to mediterranean diet

    12 months

  • body mass index (BMI)

    Body weight (in kilograms) divided by body height (in meters) squared.

    12 months

  • ventilatory threshold 1 (VT1) in spiroergometry

    ventilatory threshold VT1 in spiroergometry

    12 months

Secondary Outcomes (18)

  • stress coping capacity, as measured by the Trier Inventory for Chronic Stress (TICS) questionnaire

    3, 12, 24, 36 months

  • grade of optimism, as measured by the Life Orientation Test (LOT) questionnaire

    3, 12, 24, 36 months

  • attitudes and beliefs regarding physical training and healthy diet, as measured by the "Bewertung körperlicher Aktivität und Ernährung" (BKAE) questionnaire

    3, 12, 24, 36 months

  • quality of life, as measured by the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (EORTC QLQ-C30)

    3, 12, 24, 36 months

  • maximum oxygen consumption (VO2max), as measured by spiroergometry

    3, 12 months

  • +13 more secondary outcomes

Study Arms (2)

Control

NO INTERVENTION

Study participants are instructed regarding a healthy diet according to the recommendations of the German Nutrition Society (DGE) and are informed about positive effects of physical activity on incidence and prognosis of breast cancer

Intervention

EXPERIMENTAL

Structured exercise training plus mediterranean diet: Study participants receive a lifestyle intervention of 12 months duration (3 months intensive intervention plus 9 months maintenance using monthly contacts and meetings). The intervention comprises a structured intensified training based on the results of physical performance diagnostics and a nutrition program based on a mediterranean diet.

Behavioral: Structured exercise training plus mediterranean diet

Interventions

Structured exercise training plus mediterranean diet

Intervention

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • proven pathogenic BRCA1/2 mutation
  • age \>=18
  • written informed consent

You may not qualify if:

  • metastatic tumor disease
  • life expectancy \<3 years
  • clinically limiting cardiovascular or respiratory disease (instable CVD, heart failure stage IV, COPD GOLD IV, maximum resting blood pressure 160/100 mmHg)
  • significant orthopedic disability which prevents from participating in the group interventions
  • severe concomitant diseases which prevents from participating in the group interventions
  • Karnofsky index \<60
  • maximum exercise capacity \<50 W
  • food allergies which prevent from mediterranean diet
  • vegan diet
  • body mass index \<15 kg/m2
  • pregnancy
  • insufficient knowledge of German language
  • insufficient compliance
  • active participation in other interventional trials

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (19)

Humboldt Universität zu Berlin

Berlin, Germany

RECRUITING

Uniklinikum Köln

Cologne, Germany

RECRUITING

Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden

Dresden, Germany

RECRUITING

Universitätsklinikum Düsseldorf

Düsseldorf, Germany

RECRUITING

Kliniken Essen-Mitte

Essen, Germany

RECRUITING

Universitätsklinikum Essen

Essen, Germany

RECRUITING

Universitätsklinikum Freiburg

Freiburg im Breisgau, Germany

RECRUITING

Universitätsmedizin Göttingen

Göttingen, Germany

RECRUITING

Universitätsklinikum Hamburg-Eppendorf

Hamburg, Germany

RECRUITING

Medizinische Hochschule Hannover

Hanover, Germany

RECRUITING

Universitätsklinium Heidelberg

Heidelberg, Germany

RECRUITING

Universitätsklinikum Schleswig-Holstein, Campus Kiel

Kiel, Germany

RECRUITING

Universitätsklinikum Leipzig

Leipzig, Germany

NOT YET RECRUITING

Technische Universität München

München, Germany

RECRUITING

Universität Regensburg

Regensburg, Germany

RECRUITING

Interdisziplinäres Brustzentrum am Diakonieklinikum

Stuttgart, Germany

RECRUITING

Universitätsklinikum Tübingen

Tübingen, Germany

RECRUITING

Universität Ulm

Ulm, Germany

RECRUITING

Universitätsklinikum Würzburg

Würzburg, Germany

RECRUITING

Related Publications (2)

  • Seethaler B, Nguyen NK, Basrai M, Kiechle M, Walter J, Delzenne NM, Bischoff SC. Short-chain fatty acids are key mediators of the favorable effects of the Mediterranean diet on intestinal barrier integrity: data from the randomized controlled LIBRE trial. Am J Clin Nutr. 2022 Oct 6;116(4):928-942. doi: 10.1093/ajcn/nqac175.

  • Kiechle M, Engel C, Berling A, Hebestreit K, Bischoff SC, Dukatz R, Siniatchkin M, Pfeifer K, Grill S, Yahiaoui-Doktor M, Kirsch E, Niederberger U, Enders U, Loffler M, Meindl A, Rhiem K, Schmutzler R, Erickson N, Halle M. Effects of lifestyle intervention in BRCA1/2 mutation carriers on nutrition, BMI, and physical fitness (LIBRE study): study protocol for a randomized controlled trial. Trials. 2016 Jul 29;17:368. doi: 10.1186/s13063-016-1504-0.

MeSH Terms

Conditions

Hereditary Breast and Ovarian Cancer Syndrome

Interventions

Diet, Mediterranean

Condition Hierarchy (Ancestors)

Breast NeoplasmsNeoplasms by SiteNeoplasmsOvarian NeoplasmsEndocrine Gland NeoplasmsNeoplastic Syndromes, HereditaryOvarian DiseasesAdnexal DiseasesGenital Diseases, FemaleFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesGenital Neoplasms, FemaleUrogenital NeoplasmsGenital DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesBreast DiseasesSkin DiseasesSkin and Connective Tissue DiseasesEndocrine System DiseasesGonadal Disorders

Intervention Hierarchy (Ancestors)

Diet, Plant-BasedDiet TherapyNutrition TherapyTherapeuticsDietNutritional Physiological PhenomenaDiet, Food, and NutritionPhysiological Phenomena

Study Officials

  • Marion Kiechle, Prof. Dr.

    Technical University of Munich

    STUDY DIRECTOR
  • Martin Halle, Prof. Dr.

    Technical University of Munich

    STUDY DIRECTOR
  • Stephan C Bischoff, Prof. Dr.

    Universitaet Hohenheim, Stuttgart

    STUDY DIRECTOR
  • Michael Siniatchkin, Prof. Dr.

    University Hospital Schleswig-Holstein

    STUDY DIRECTOR
  • Markus Loeffler, Prof. Dr.

    University of Leipzig

    STUDY DIRECTOR
  • Christoph Engel, PD Dr.

    University of Leipzig

    STUDY DIRECTOR
  • Rita K Schmutzler, Prof. Dr.

    University of Cologne

    STUDY DIRECTOR
  • Alfons Meindl, Prof. Dr.

    Technical University of Munich

    STUDY DIRECTOR
  • Anne S Quante, Dr.

    Technical University of Munich

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marion Kiechle, Prof. Dr.

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 22, 2015

First Posted

August 6, 2015

Study Start

March 1, 2015

Primary Completion

March 1, 2025

Study Completion

March 1, 2025

Last Updated

April 11, 2024

Record last verified: 2024-04

Locations